Probing SARS-CoV-2 membrane binding peptide via single-molecule AFM-based force spectroscopy.

Zhang Q, Rosa RSL, Ray A, Durlet K, Dorrazehi GM, Bernardi RC, Alsteens D
Nature communications 2025 doi:10.1038/s41467-024-55358-9 PubMed
AFM force spectroscopy

Biological system

  • SARS-CoV-2 spike membrane-binding peptide MBP1 (TMPRSS2-primed form, spike residues 816-855) · peptide
  • SARS-CoV-2 spike membrane-binding peptide MBP2 (unprimed form, spike residues 806-855) · peptide
  • SARS-CoV-2 spike S2 subunit (His-tagged, Wuhan-1) · protein
  • Supported lipid bilayer, DOPC/cholesterol (70/30) · protein
  • Supported lipid bilayer, DOPC/brain sphingomyelin (70/30) · protein
  • TMPRSS2 (used to cleave/prime the S2 subunit) · protein

Data availability

Abstract

The SARS-CoV-2 spike protein's membrane-binding domain bridges the viral and host cell membrane, a critical step in triggering membrane fusion. Here, we investigate how the SARS-CoV-2 spike protein interacts with host cell membranes, focusing on a membrane-binding peptide (MBP) located near the TMPRSS2 cleavage site. Through in vitro and computational studies, we examine both primed (TMPRSS2-cleaved) and unprimed versions of the MBP, as well as the influence of its conserved disulfide bridge on membrane binding. Our results show that the MBP preferentially associates with cholesterol-rich membranes, and we find that cholesterol depletion significantly reduces viral infectivity. Furthermore, we observe that the disulfide bridge stabilizes the MBP's interaction with the membrane, suggesting a structural role in viral entry. Together, these findings highlight the importance of membrane composition and peptide structure in SARS-CoV-2 infectivity and suggest that targeting the disulfide bridge could provide a therapeutic strategy against infection.